According to MEI Pharma latest financial reports the total debt is $11.30M, an increase of 28.83% to 2022. At the end of 2022 company had $8.77M total debt. This figure represents the debts and financial obligations that MEI Pharma combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $11.30M | 28.83% |
2022 | $8.77M | 19.01% |
2021 | $7.37M | Infinity% |
2020 | $0 | - |